A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model

被引：0
|
作者：
Ciccone, D. [1 ]
Lazari, V. [2 ]
Linney, I. [2 ]
Briggs, M. [2 ]
Carreiro, S. [1 ]
Waddell, I. [2 ]
Hill, C. [2 ]
Loh, C. [1 ]
Tummino, P. [1 ]
Collis, A. [1 ]
Kaila, N. [1 ]
机构：
[1] Nimbus Therapeut, Res & Dev, Cambridge, MA USA
[2] Charles River Labs, Res, Chesterford Pk, England
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
46
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [21] MAP4K1 inhibition enhances immune cell activation and anti-tumor immunity in preclinical tumor models.
    Faia, Kerrie
    Toso, Alberto
    Fetalvero, Kristina
    Roche, Marly
    Bench, Steven
    O'Hearn, Erin
    Cao, Qiongfang
    Bright, Kerry-Ann
    Paduraru, Debora
    Romagnani, Andrea
    Weng, Weifan
    Zimmermann, Tina
    Burke, Michael
    Close, Joshua
    Green, Luke
    Kim, Joseph
    Miduturu, Chandra
    Ribeiro, Alison
    Bacac, Marina
    Herter, Sylvia
    Perola, Emanuele
    Sheets, Michael
    Eckmann, Jan
    Heidkamp, Gordon
    Traore, Tary
    Gerson, Erik
    Woessner, Rich
    Wolter, Carsten
    Scheuplein, Felix
    Perez, Nisha
    LaBranche, Timothy
    Silva, Grace
    Ye, Chaoyang
    Utt, Caitlin
    Gross, Stefan
    Bischoff, James R.
    Dorsch, Marion
    Guzi, Tim
    Hoeflich, Klaus
    Brubaker, Jason
    CANCER RESEARCH, 2021, 81 (13)
  • [22] AVA-NP-695, a potent and selective ENPP1 inhibitor, abrogates tumor metastasis in 4T1 syngeneic tumor model and demonstrates strong tumor regression when combined with radiation
    Kulkarni, Aditya
    Goswami, Avijit
    Goyal, Sandeep
    Khurana, Princy
    Ghoshal, Ishani
    CANCER RESEARCH, 2023, 83 (07)
  • [23] Targeted delivery of interleukin-12 to HER2-expressing tumor induces a therapeutic T cell-mediated immune response in a syngeneic murine bladder tumor model
    Tsai, Y. S.
    Tzai, T. S.
    Wu, C. L.
    Shiau, A. L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 117 - 117
  • [24] Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition
    Dirk Zboralski
    Frank Osterkamp
    Esben Christensen
    Anne Bredenbeck
    Anne Schumann
    Aileen Hoehne
    Eberhard Schneider
    Matthias Paschke
    Jan Ungewiss
    Christian Haase
    Liliane Robillard
    Andrew D. Simmons
    Thomas C. Harding
    Minh Nguyen
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2621 - 2635
  • [25] Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition
    Zboralski, Dirk
    Osterkamp, Frank
    Christensen, Esben
    Bredenbeck, Anne
    Schumann, Anne
    Hoehne, Aileen
    Schneider, Eberhard
    Paschke, Matthias
    Ungewiss, Jan
    Haase, Christian
    Robillard, Liliane
    Simmons, Andrew D.
    Harding, Thomas C.
    Nguyen, Minh
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (09) : 2621 - 2635
  • [26] Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines
    Thomson, Douglas W.
    Wagner, Anne J.
    Bantscheff, Marcus
    Benson, R. Edward
    Dittus, Lars
    Duempelfeld, Birgit
    Drewes, Gerard
    Krause, Jana
    Moore, John T.
    Mueller, Katrin
    Poeckel, Daniel
    Rau, Christina
    Salzer, Elsa
    Shewchuk, Lisa
    Hopf, Carsten
    Emery, John G.
    Muelbaier, Marcel
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5455 - 5471
  • [27] A potent and selective allosteric PTP4A3 phosphatase inhibitor enhances microvascular barrier function and inhibits human tumor cell growth
    Lazo, John Stephen
    McQueeney, Kelley E.
    Salamoun, Joseph M.
    Barabutis, Nektarios
    Catravas, John D.
    Wipf, Peter
    FASEB JOURNAL, 2018, 32 (01):
  • [28] Extracts from Citrus unshiu promote immune-mediated inhibition of tumor growth in a murine renal cell carcinoma model
    Lee, Sanggon
    Ra, Jehyeon
    Song, Ju-Young
    Gwak, ChangHo
    Kwon, Ha-Jeong
    Yim, Sung-Vin
    Hong, Seon-Pyo
    Kim, Jinju
    Lee, Kun-Hee
    Cho, Jeong-Je
    Park, Yong Seek
    Park, Cheung-Seog
    Ahn, Hyun-Jong
    JOURNAL OF ETHNOPHARMACOLOGY, 2011, 133 (03) : 973 - 979
  • [29] Derazantinib, a fibroblast growth factor receptor inhibitor, inhibits colony-stimulating factor receptor-1 in macrophages and tumor cells and in combination with a murine programmed cell death ligand-1-antibody activates the immune environment of murine syngeneic tumor models
    El Shemerly, Mahmoud
    Zanini, Elisa
    Lecoultre, Marc
    Walker, Paul R.
    Kellenberger, Laurenz
    Lane, Heidi A.
    Mcsheehy, Paul M. J.
    ANTI-CANCER DRUGS, 2023, 34 (09) : 1035 - 1045
  • [30] BI 2536, a potent and highly selective inhibitor of polo-like kinase 1 (Plk1) induces mitotic arrest and apoptosis in a broad spectrum of tumor cell lines.
    Steegmaier, M
    Baum, A
    Solca, F
    Peters, JM
    Grauert, M
    Hoffmann, M
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9147S - 9147S
12345